Now is the Time to Invest in Rare Disease
Why Now is the Time to Invest in Rare Disease Therapies As a new administration takes charge and the spotlight intensifies on the challenges posed by big pharma, the pharmaceutical industry faces both scrutiny and opportunity. Amid this evolving landscape, a compelling case emerges for investing in the development of rare disease therapies. These treatments, […]